Company intelligence / Profile preview

ChemRoutes

Edmonton, Alberta, Canadachemroutes.com ↗

Ownership: Private
Employees: ~32
Development stage: Other

Overview

ChemRoutes provides unique, patentable small molecule chemical libraries and scaffolds not available in the public domain. Their offerings support early-stage drug discovery across multiple therapeutic areas by enabling access to novel chemotypes targeting GPCRs, kinases, ion channels, etc. They have global partnerships with over 80 pharmaceutical/agrochemical/biotech companies. No direct clinical results as they are a platform/provider.

Therapeutic areas: Metabolic DisordersNeurologyInfectious DiseasesOncologyRheumatology
Modalities: Small moleculeChemical librariesScaffolds/templates for medicinal chemistry and drug discovery
Industry: Drug Discovery Services

Partnerships

Over 80 global pharmaceutical/agrochemical/biotech partners

Beyond the preview

Go deeper on ChemRoutes.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemRoutes.

Explore the full profile